Mangiferin-containing compositions for improving sports performance
US11376294B2 · kind B2 · utility
0Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2019 |
| Grant date | Jul 5, 2022 |
| Priority date | — |
| Expiry date | Nov 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for enhancing at least one of alertness, attention, concentration and memory in a person in need thereof, comprising co-administering an effective amount of mangiferin, norathyriol, or an extract comprising mangiferin or norathyriol; and caffeine to the person. The components may be co-administered in a single composition, or administered in separate compositions. The mangiferin and/or norathyriol exhibit synergistic effects on brain wave activity when co-administered with caffeine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.